课题基金 / 基金详情

CANCER GENETICS NETWORK

CANCER GENETICS NETWORK
癌症遗传学网络
批准号:
7281428
负责人:
Claudine Isaacs
金额:
$8.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 2007-09-30

项目摘要

项目成果

Claudine Isaacs的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Applicant's Description) While advances in cancer genetics are occurring at rapid pace, critical questions about genetic susceptibility and prevention remain unanswered. In response to the RFA for the Cancer Genetics Network, we propose to: (1) Enroll substantial numbers of the following populations into the CGN: (a) hereditary breast, ovarian, and colon cancer families, (b) newly diagnosed high risk breast cancer patients, and (c) persons at low to moderate risk of cancer; (2) Utilize our existing networks of community-based hospitals and primary care clinics to increase CGN enrollment of African Americans and Latin Americans in the Washington, D.C. area; (3) Contribute our well-validated IRB-approved protocols for informed consent, pre-test education, and genetic counseling to the CGN; (4) Provide CGN investigators with access to our state-of-the-art laboratory technologies for diagnostic genetic analysis; (5) Utilize our existing infrastructure for cancer DNA/tissue collection, processing, and storage to contribute to basic cancer genetics research in the CGN; (6) Modify existing cancer genetics educational materials to target African Americans and develop Spanish language materials, consent forms and counseling protocols for use with Latin Americans; (7) Provide genetics education and training programs for a wide range of healthcare providers, including nurses and medical students; and (8) Contribute our expertise conducting research on the clinical, psychosocial, and economic outcomes of genetic testing for cancer susceptibility.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians.
他莫昔芬作为 BRCA1 和 BRCA2 突变携带者乳腺癌的化学预防:一项针对医生的试点调查。
DOI: 10.1200/jco.2003.02.107
发表时间: 2003
期刊: Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
影响因子: --
作者: [Peshkin,BethN, Isaacs,Claudine, Finch,Clinton, Kent,Sheryl, Schwartz,MarcD]
通讯作者: Schwartz,MarcD
BRCA mutation testing in determining breast cancer therapy.
BRCA 基因突变检测在确定乳腺癌治疗中的作用。
DOI: 10.1097/ppo.0b013e318238f579
发表时间: 2011-11
期刊: Cancer journal (Sudbury, Mass.)
影响因子: --
作者: [Smith KL, Isaacs C]
通讯作者: Isaacs C
THE FAMILIAL CANCER REGISTRY
  • 批准号:
    7951980
  • 项目类别:
  • 资助金额:
    $16.83万
  • 财政年份:
    2009
  • 负责人:
    Claudine Isaacs
  • 依托单位:
A TRIAL OF EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH DCIS OR AT HIGH RISK FOR INVA
  • 批准号:
    7952008
  • 项目类别:
  • 资助金额:
    $3.11万
  • 财政年份:
    2009
  • 负责人:
    Claudine Isaacs
  • 依托单位:
CANCER GENETICS NETWORK (CGN) OVARIAN SCREENING PILOT TRIAL IN HIGH RIS WOMEN
  • 批准号:
    7719027
  • 项目类别:
  • 资助金额:
    $2.14万
  • 财政年份:
    2008
  • 负责人:
    Claudine Isaacs
  • 依托单位:
THE FAMILIAL CANCER REGISTRY
  • 批准号:
    7719043
  • 项目类别:
  • 资助金额:
    $9.49万
  • 财政年份:
    2008
  • 负责人:
    Claudine Isaacs
  • 依托单位:
海外基金